ZacheryRogerReichertMD

Oncology • Ann Arbor, MI

Physician

Join to view full profile

Dr. Reichert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reichert's full profile

Already have an account?

Office
1500 E Medical Center Dr
3116 Taubman Center, Spc 5368
Ann Arbor, MI 48109
Phone+1 734-936-4385

Education & Training

University of MichiganResidency, Internal Medicine, 2013
Johns Hopkins University School of MedicineClass of 2010

Certifications & Licensure

MI State Medical License 2010 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) Start of enrollment: 2018 Dec 10
Completed
Phase 2

Publications & Presentations

PubMed

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics.
Zeqi Niu, Molly Kozminsky, Kathleen C Day, Luke J Broses, Marian L Henderson
Neoplasia. 2024-11-01
Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing.
Sophia M Abusamra, Marissa A Solorzano, Jake Quarles, Mallory Luke, Milan Patel
Urology Practice. 2024-10-09
1 citations
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).
Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, Nabil Adra, Jingsong Zhang
Clinical Cancer Research. 2024-10-01

Journal Articles

Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell Carcinoma
Aaron M Udager, Andrew S Mcdaniel, Simpa S Salami, Samuel D Kaffenberger, Jeffrey S Montgomery, Alon Z Weizer, Zachery R Reichert, Ajjai S Alva, Arul M Chinnaiyan, Sco..., European Urology

Lectures

Focal radiation for oligometastatic castration-resistant prostate cancer (FORCE): A phase II randomized trial.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

Despite Benefits, Extended-Interval Pembro Uptake Remains LowSeptember 28th, 2022
Predicting Complications of Cytoreductive Nephrectomy in Metastatic RCCSeptember 25th, 2020
Predicting Complications of Cytoreductive Nephrectomy in Metastatic RCCSeptember 25th, 2020